These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35033209)

  • 1. LEADD: Lamarckian evolutionary algorithm for de novo drug design.
    Kerstjens A; De Winter H
    J Cheminform; 2022 Jan; 14(1):3. PubMed ID: 35033209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo drug design using multiobjective evolutionary graphs.
    Nicolaou CA; Apostolakis J; Pattichis CS
    J Chem Inf Model; 2009 Feb; 49(2):295-307. PubMed ID: 19434831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RetroGNN: Fast Estimation of Synthesizability for Virtual Screening and De Novo Design by Learning from Slow Retrosynthesis Software.
    Liu CH; Korablyov M; Jastrzębski S; Włodarczyk-Pruszyński P; Bengio Y; Segler M
    J Chem Inf Model; 2022 May; 62(10):2293-2300. PubMed ID: 35452226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design.
    Chu Y; He X
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30979097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RENATE: A Pseudo-retrosynthetic Tool for Synthetically Accessible de novo Design.
    Ghiandoni GM; Bodkin MJ; Chen B; Hristozov D; Wallace JEA; Webster J; Gillet VJ
    Mol Inform; 2022 Apr; 41(4):e2100207. PubMed ID: 34750989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-objective Genetic Algorithm for De Novo Drug Design (MoGADdrug).
    Devi RV; Sathya SS; Coumar MS
    Curr Comput Aided Drug Des; 2021; 17(3):445-457. PubMed ID: 32562528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Automated Structure-Based De Novo Drug Design.
    Tang Y; Moretti R; Meiler J
    J Chem Inf Model; 2024 Mar; 64(6):1794-1805. PubMed ID: 38485516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo design of drug-like molecules by a fragment-based molecular evolutionary approach.
    Kawai K; Nagata N; Takahashi Y
    J Chem Inf Model; 2014 Jan; 54(1):49-56. PubMed ID: 24372539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-based de novo ligand design by multiobjective evolutionary optimization.
    Dey F; Caflisch A
    J Chem Inf Model; 2008 Mar; 48(3):679-90. PubMed ID: 18307332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EvoMD: an algorithm for evolutionary molecular design.
    Wong SS; Luo W; Chan KC
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(4):987-1003. PubMed ID: 20876937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic algorithm for the automated generation of small organic molecules: drug design using an evolutionary algorithm.
    Douguet D; Thoreau E; Grassy G
    J Comput Aided Mol Des; 2000 Jul; 14(5):449-66. PubMed ID: 10896317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space.
    Kutchukian PS; Lou D; Shakhnovich EI
    J Chem Inf Model; 2009 Jul; 49(7):1630-42. PubMed ID: 19527020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks.
    Schneider G; Lee ML; Stahl M; Schneider P
    J Comput Aided Mol Des; 2000 Jul; 14(5):487-94. PubMed ID: 10896320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atom assignment problem in automated de novo drug design. 3. Algorithms for optimization of fragment placement onto 3D molecular graphs.
    Barakat MT; Dean PM
    J Comput Aided Mol Des; 1995 Aug; 9(4):359-72. PubMed ID: 8523045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A graph-based approach to construct target-focused libraries for virtual screening.
    Naderi M; Alvin C; Ding Y; Mukhopadhyay S; Brylinski M
    J Cheminform; 2016; 8():14. PubMed ID: 26981157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quest for novel chemical matter and the contribution of computer-aided de novo design.
    Pirard B
    Expert Opin Drug Discov; 2011 Mar; 6(3):225-31. PubMed ID: 22647201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing reaction-based de novo design using a multi-label reaction class recommender.
    Ghiandoni GM; Bodkin MJ; Chen B; Hristozov D; Wallace JEA; Webster J; Gillet VJ
    J Comput Aided Mol Des; 2020 Jul; 34(7):783-803. PubMed ID: 32112286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The atom assignment problem in automated de novo drug design. 2. A method for molecular graph and fragment perception.
    Barakat MT; Dean PM
    J Comput Aided Mol Des; 1995 Aug; 9(4):351-8. PubMed ID: 8523044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In Silico Drug Design Using an Evolutionary Algorithm and Compound Database].
    Kawai K; Takahashi Y
    Yakugaku Zasshi; 2016; 136(1):107-12. PubMed ID: 26725677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA.
    Schüller A; Suhartono M; Fechner U; Tanrikulu Y; Breitung S; Scheffer U; Göbel MW; Schneider G
    J Comput Aided Mol Des; 2008 Feb; 22(2):59-68. PubMed ID: 18064402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.